0000899243-23-010680.txt : 20230405 0000899243-23-010680.hdr.sgml : 20230405 20230405143018 ACCESSION NUMBER: 0000899243-23-010680 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230324 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Michael Terrence CENTRAL INDEX KEY: 0001665000 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 23802139 MAIL ADDRESS: STREET 1: 12 STONEY BROOK RD. CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0407 4/A 2023-03-24 2023-03-28 0 0001492674 T2 Biosystems, Inc. TTOO 0001665000 Gibbs Michael Terrence 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 General Counsel 0 Common Stock 2023-03-24 4 M 0 334 A 6851 D Restricted Stock Units 2023-03-24 4 M 0 334 0.00 D Common Stock 334 0 D The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021 /s/ John Sprague, Attorney-in-fact 2023-04-05